Quick Answer
Concord Medical Services Holdings Ltd reported Total Revenue of $383.96 million for fiscal year 2024.
Concord Medical Services Holdings Ltd — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $383.96M -28.6% |
$537.40M +13.8% |
$472.08M -2.8% |
$485.63M +117.8% |
$223.01M +12.4% |
$198.36M +3.9% |
| Revenue (ASC 606) | — | — | — | — | — | $139.80M +22.4% |
| Net Income | -$42.23M +85.8% |
-$297.66M +39.2% |
-$489.66M -80.4% |
-$271.43M +12.4% |
-$309.99M -1.0% |
-$307.05M -30.7% |
| Diluted EPS | -$2.35 -3.5% |
-$2.27 +39.3% |
-$3.74 +40.3% |
-$6.26 -22.5% |
-$5.11 | — |
| Total Assets | $921.51M -84.8% |
$6.05B +0.8% |
$6.00B -3.6% |
$6.23B +16.8% |
$5.33B +24.1% |
$4.30B -6.3% |
| Cash and Equivalents | $216.22M +271.9% |
$58.14M -63.3% |
$158.28M +0.6% |
$157.39M -52.9% |
$334.26M +349.8% |
$74.31M -81.6% |
| Long-Term Debt | $369.03M -81.5% |
$1.99B -19.3% |
$2.47B +13.4% |
$2.18B +10.7% |
$1.97B +52.4% |
$1.29B +159.6% |
| Stockholders Equity | -$2.28B -7.5% |
-$2.12B -13.8% |
-$1.86B -36.0% |
-$1.37B -106.7% |
-$662.96M -440.0% |
-$122.76M -128.1% |
| Operating Income | -$72.91M +84.3% |
-$462.99M +11.8% |
-$525.05M -14.6% |
-$458.32M -45.0% |
-$316.00M +27.7% |
-$437.29M -46.1% |
| Gross Profit | -$79.16M -3.3% |
-$76.61M +49.7% |
-$152.41M -167.9% |
-$56.90M -534.9% |
$13.08M +182.6% |
-$15.83M -180.1% |
| Shares Outstanding | — | — | — | — | — | — |
- Concord Medical Services Holdings Ltd reported Total Revenue of $383.96 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed a decrease of -28.6% in Total Revenue compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Revenue (ASC 606) of $139.80 million for fiscal year 2019.
- Concord Medical Services Holdings Ltd showed an increase of +22.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Net Income of -$42.23 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed an increase of +85.8% in Net Income compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Diluted EPS of $2.35 per share (loss) for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed a decrease of -3.5% in Diluted EPS compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Total Assets of $921.51 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed a decrease of -84.8% in Total Assets compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Cash and Equivalents of $216.22 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed an increase of +271.9% in Cash and Equivalents compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Long-Term Debt of $369.03 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed a decrease of -81.5% in Long-Term Debt compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Stockholders Equity of -$2.28 billion for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed a decrease of -7.5% in Stockholders Equity compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Operating Income of -$72.91 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed an increase of +84.3% in Operating Income compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Gross Profit of -$79.16 million for fiscal year 2024.
- Concord Medical Services Holdings Ltd showed a decrease of -3.3% in Gross Profit compared to the prior fiscal year.
- Concord Medical Services Holdings Ltd reported Shares Outstanding of 130.09 million shares for fiscal year 2017.
- Concord Medical Services Holdings Ltd showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: